New vaccine targets group b strep in seniors
⭐️ VACCINE ⭐️
Completed
This early-stage trial tested a new vaccine against Group B Streptococcus (GBS) in 90 healthy adults aged 55 to 75. Participants received three doses of the vaccine or a placebo, and researchers monitored safety and immune response for six months. The goal is to see if the vaccin…
Phase: PHASE1 • Sponsor: Minervax ApS • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 13:27 UTC